MedTrace Logo

Anti-Proteinuric Response to ACEI, ARB and Diuretics Combination.

NCT00200694 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 18

Last updated 2009-02-04

No results posted yet for this study

Summary

Determine the best strategy for proteinuria lowering in patients with proteinuria \> 1 g/day receiving ACEI and ARB combination: either increase of ACEI and ARB dosage or increase of diuretic dosage.

Conditions

  • Heavy Proteinuria

Interventions

DRUG

ramipril 5 mg + valsartan 80 mg/day,

DRUG

ramipril 10 mg + valsartan 160 mg/day,

DRUG

ramipril 5 mg + valsartan 80 mg/day + increased dosage of furosémide.

Sponsors & Collaborators

  • Nantes University Hospital

    lead OTHER

Principal Investigators

  • Vincent LM Esnault, MD PHD · Nantes University Hospital

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31
Primary Completion
2007-03-31
Completion
2007-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00200694 on ClinicalTrials.gov